Millions of people to view digital prescriptions via the NHS app
PharmaTimes
FEBRUARY 1, 2024
Prescriptions ordered via the app are expected to save around 1.85 million hours in 2024
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
PharmaTimes
FEBRUARY 1, 2024
Prescriptions ordered via the app are expected to save around 1.85 million hours in 2024
Healthcare Success
JANUARY 2, 2024
Now that the holidays have drawn to a close, it’s time to return to your 2024 marketing plan and make adjustments that ensure your business is taking advantage of the latest trends in healthcare marketing to reach patients and HCPs more effectively and make a lasting impression.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
DECEMBER 20, 2024
Swoop Launched in September 2024, the Swoop HCP Pro Suite is revolutionizing how pharmaceutical marketers engage with healthcare providers (HCPs). By tailoring messaging frequency and content to align with patient care journeys, marketers eliminate waste, improve engagement, and drive higher prescription lift.
PM360
DECEMBER 20, 2024
After nearly five years of mounting pressures on the American healthcare system, providers and patients are confronting another challenge that shows no signs of slowing down: skyrocketing medical costs. Pharmacies are also feeling the impact, as unaffordable medication costs lead to prescription abandonment, undermining long-term care plans.
Eversana Intouch
MARCH 19, 2024
And this month, we’re bringing to light the challenges in women’s healthcare that we can help solve and make history together. When it comes to healthcare, however, this model often fails to consider the good of all. That’s why in 2024, we find ourselves still failing women in healthcare.
Nixon Gwilt Law
JANUARY 16, 2024
What can digital health innovators and investors anticipate for the industry in 2024? What can digital health innovators and investors anticipate for the industry in 2024? We asked our team to share their insights on healthcare innovation, new regulations, and trends we expect to impact your business this year. We know a few!
Nixon Gwilt Law
JANUARY 16, 2024
What can digital health innovators and investors anticipate for the industry in 2024? We asked our team to share their insights on healthcare innovation, new regulations, and trends we expect to impact your business this year. Read on to find out what else is on our Legal Vision Board for 2024! A close second would be Anthropic.”
PM360
NOVEMBER 13, 2023
Improving healthcare and patient outcomes requires that stakeholders communicate and collaborate, and GoodRx is one of the few places where providers, patients, and pharma can connect every single day. That’s rare in healthcare, and we believe it likely improves communication and joint decision making along their health journey together.
PM360
MAY 23, 2024
For example, Bryan’s leadership played a pivotal role in the design and development of Veeva Compass’ modern data products—Veeva Compass Prescriber and National—featuring prescriber -and national- level projections based on both prescription and medical claims. As rare diseases affect about 1 in 10 people in the U.S.,
Pharmaceutical Technology
JULY 28, 2022
Prescription of daily oral aripiprazole continues to dominate the use of Otsuka and Lundbeck’s once-monthly LAI formulation Abilify Maintena and Alkermes’ Aristada, which can be administered every six weeks. KOLs noted that in an outpatient setting, many psychiatrists are ill-equipped to administer these injectables.
European Pharmaceutical Review
OCTOBER 17, 2024
In August 2024, the European Commission approved EURneffy (adrenaline nasal spray) in the EU as the first needle-free emergency option to treat anaphylaxis. Poster Presented at the 2024 AAAAI Annual meeting, DC, US. This decision was granted a couple of weeks following approval by the US and Drug Administration (FDA).
Nixon Gwilt Law
JUNE 24, 2024
The Digital Therapeutics Alliance Summit 2024 , held in Washington, D.C., Research indicates that patient outcomes significantly improve when patients feel like they have an important role in their healthcare journeys. Instead of limiting themselves under a prescription-based model, founders should explore alternative revenue streams.
PM360
SEPTEMBER 21, 2023
As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. CMS will present an initial offer for each drug’s maximum fair price (MFP) by February 1, 2024.
PM360
OCTOBER 22, 2024
Improving our collective understanding of the patient’s overall healthcare experience is necessary to effectively deliver prescription support. How can we ensure that vital prescription information reaches patients when they need it?
Nixon Gwilt Law
JUNE 24, 2024
The Digital Therapeutics Alliance Summit 2024 , held in Washington, D.C., Research indicates that patient outcomes significantly improve when patients feel like they have an important role in their healthcare journeys. Instead of limiting themselves under a prescription-based model, founders should explore alternative revenue streams.
pharmaphorum
JANUARY 24, 2023
In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.
European Pharmaceutical Review
JULY 4, 2024
1 For use as prescription drugs, a botanical product must be approved by the FDA: to date, only two have gained this approval. 2 Approach taken by regulators in the UK The Medicines and Healthcare products Regulatory Agency regulates herbal medicines in the UK. 13 Currently, over 350 herbal remedies have been granted a THR licence.
PM360
MAY 21, 2024
Navigating the complex healthcare system can be a stressful experience for patients, from obtaining a diagnosis to finding the right specialty care or treatment. Additionally, delivering content about screenings to patients when they’re already in a healthcare state of mind can lead to better health outcomes.
Nixon Gwilt Law
JUNE 27, 2024
At the most recent Food as Medicine (FaM) Summit, leading experts, policymakers, and healthcare innovators in FaM gathered to discuss one important goal: revolutionizing how we improve population health through food and nutritional guidance. Here’s what we believe every healthcare and FaM innovator should know. in healthcare costs.
Nixon Gwilt Law
JUNE 27, 2024
At the most recent Food as Medicine (FaM) Summit, leading experts, policymakers, and healthcare innovators in FaM gathered to discuss one important goal: revolutionizing how we improve population health through food and nutritional guidance. Here’s what we believe every healthcare and FaM innovator should know. in healthcare costs.
European Pharmaceutical Review
JANUARY 5, 2023
Triomphe added: “… it is our intention to make nirsevimab available, if approved in time, for the 2023/2024 season to help alleviate the burden of RSV on families and the healthcare system.”. The Prescription Drug User Fee Act date, the FDA target action date for their decision, is in the third quarter of 2023.
PM360
NOVEMBER 21, 2024
Corcept’s DSE campaign aims to drive awareness of endogenous hypercortisolism among healthcare professionals (HCPs) treating patients with difficult-to-control T2D, leveraging a word search puzzle to demonstrate the hidden nature of the condition.
Clarivate
MAY 13, 2024
According to Clarivate’s latest enrollment data, as of January 2024, Medicaid enrollment had plummeted by nearly 9 million compared to six months prior. For 2024, 18% of enrollees were new to exchange coverage, according to the Centers for Medicare and Medicaid Services. million between January 2023 and January 2024. to about 2.5
PM360
MAY 21, 2024
The cost of filling a prescription can keep 21% of patients from getting an Rx, and one in ten patients will modify their treatment plan because of cost, according to recent polling data from KFF. When treatments are missed or reduced, health outcomes suffer.
pharmaphorum
OCTOBER 3, 2022
The third ALS treatment to be given FDA approval, following Mitsubishi Tanabe’s Radicava ($170,000 per year) and generic drug riluzole – Relyvrio is priced at around $12,500 per 28-day prescription. Clearer’ data isn’t expected until 2024, with results from a late-stage phase 3 PHOENIX trial of around 600 patients due at that time.
PM360
SEPTEMBER 30, 2024
By involving patients early, healthcare companies can gather critical insights into user behavior, preferences, and pain points. This integration allows patients to book appointments, access their medication history, and manage prescriptions all in one place, simplifying their experience.
PM360
NOVEMBER 14, 2023
However, in August news outlets reported that even with industry and government initiatives to lower the cost of insulin, the implementation had been slow due to healthcare system “mechanics,” and a significant number of consumers had not yet benefited from the $35 insulin options. for only $35. Currently, an estimated 37.3 of the U.S.
Legacy MEDSearch
MARCH 7, 2024
Dexcom disclosed its plans to make Stelo available for purchase online without the need for a prescription, starting in summer 2024. The device relies on a wearable sensor, which communicates with a smartphone application to continuously monitor blood glucose levels providing valuable insight into users’ blood sugar fluctuations.
PM360
OCTOBER 22, 2024
With 30% of the world’s data volume generated by the healthcare industry, defining and aligning meaningful metrics is challenging.¹ To define metrics, understand trends, measure success, and make impactful decisions, medical affairs teams must make sense of the vast amount of healthcare data. Tracking patient-related metrics (e.g.,
PM360
NOVEMBER 21, 2024
The Branded Campaign: The “Mite Party” campaign uses animated, approachable mites to visualize the disease, destigmatize Demodex blepharitis, and educate patients about XDEMVY, the first and only prescription treatment that targets and kills the mites that cause the disease. The team’s work was innovative in several key ways.
PM360
NOVEMBER 21, 2024
Winning a Lifetime Achievement Award after 40+ Years of Leadership Labcorp’s Adam Schechter was presented a Lifetime Achievement Award at the 2024 Trailblazer Awards, which took place at Gotham Hall in New York City, October 1. Adam is an ethical leader who leads his business to serve the needs of patients and advance healthcare globally.
PM360
OCTOBER 22, 2024
Pharma brands work diligently to win the trust of key stakeholders—namely patients, caregivers, and healthcare providers (HCPs). They become supportive extensions of the brand that work on a personalized level with patients and care teams, from the moment the prescription is written to other important points along the treatment journey.
PM360
OCTOBER 22, 2024
Real-world data (RWD) is a critical tool for advancing healthcare innovation, improving health outcomes, lowering the cost of care, improving healthcare quality, reducing barriers to access, and closing health disparities. Insurers may require prior authorization or step therapy before approving the preferred prescription.
PM360
SEPTEMBER 21, 2023
This product would be a more potent prescription version than the OTCs, Casberg notes. In 2024, ARPA removes the 100% AMP cap. The company says it will produce two million doses a year and give away half of them for free, while the rest will be sold at roughly $18 per dose.
Clarivate
OCTOBER 30, 2022
Of surveyed MCOs that cover or plan to cover DTx apps for the three conditions, more than 80% of respondents reported reimbursing DTx for at least one of the conditions in their fully insured commercial plans as of March 2022, with the remainder expecting to do so by 2024. Payers also noted some coverage in their Medicare and Medicaid plans.
PM360
SEPTEMBER 30, 2024
But commercializing an oncology product in 2024 means identifying and linking to an authentic shortfall in the lived experience of a patient with cancer, not just a perceived gap in the market. For example, national healthcare or private insurance coverage may provide access to a drug but not reimburse its companion diagnostic.
Clarivate
DECEMBER 19, 2022
Insurers that incentivize using Walmart facilities in Medicare Advantage and prescription drug plans (PDPs) have seen success; Humana has a long-running standalone Part D plan with Walmart pharmacies as preferred network locations. To learn more about how Clarivate helps life science companies navigate the fast-changing U.S.
Pharmaceutical Representative Training
JUNE 22, 2024
In an effort to reduce the hazards connected with their use, regulations seek to regulate the prescription and distribution of these drugs. The Department of Justice (DOJ) accused this company of providing lavish meals, entertainment, and speaker fees to healthcare providers (HCPs) to induce them to prescribe their drugs. link] ACMA.
PM360
JUNE 24, 2024
prescriptions, medical devices, or other treatments). No one actually knows for sure until the prescription is sent for prior authorization. Ultimately, patients and their care partners learn to become their own advocates and better consumers of healthcare. The process for prior authorization is complicated, however.
PM360
NOVEMBER 12, 2023
We can expect individual states to continue advancing their own privacy legislation, and cookies are officially disappearing after June 30, 2024, to boot. And what are the best tools and techniques to optically target patients and healthcare providers without running afoul of new regulations?
PM360
AUGUST 7, 2024
Whether you’re a social media manager aiming to enhance engagement, a medical affairs professional measuring the impact of healthcare initiatives, or a marketer refining campaign effectiveness, it is important to understand how to create the best possible outcome for your campaigns and programs.
PM360
SEPTEMBER 28, 2022
In April 2022, we released an article describing proposed policies from the federal government that could impact prescription drug pricing. healthcare system with major implications for the Medicare Advantage and Medicare Part D programs. On August 16, 2022, President Biden signed the Inflation Reduction Act (IRA) into law.
PM360
AUGUST 12, 2024
The 2024 festival received over 500 films from over 60 countries across the globe, including Iran, US, Greece and Russia, among others. The festival is an international film festival focusing exclusively on health and wellness. CINEHEALTH works to bring the community together through patient and HCP engagement using innovative storytelling.
PM360
MARCH 22, 2024
CMI Media Group has a strong and lasting heritage in the United States, known for highly effective healthcare audience reach. For nearly 35 years, CMI has been the leader in the American healthcare media landscape, fully focused on delivering successful media strategies to U.S.-based prescribers. The need for a media consolidation.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content